Ikena Oncology Inc

NEW
NAS:IKNA (USA)  
$ 1.32 -0.010 (-0.75%) 12:08 AM EST
At Loss
P/B:
0.51
Market Cap:
$ 63.70M
Enterprise V:
$ -53.16M
Volume:
12.55K
Avg Vol (2M):
122.32K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
12.55K
At Loss
Avg Vol (2M):
122.32K

Business Description

Description
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
Name Current Vs Industry Vs History
Cash-To-Debt 16.54
Equity-to-Asset 0.89
Debt-to-Equity 0.06
Debt-to-EBITDA -0.14
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.8
Quick Ratio 11.8
Cash Ratio 11.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.3
Shareholder Yield % -0.86

Financials (Next Earnings Date:2025-05-13 Est.)

IKNA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IKNA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Ikena Oncology Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.01
Beta 0.53
3-Year Sharpe Ratio -0.22
3-Year Sortino Ratio -0.32
Volatility % 40.19
14-Day RSI 43.56
14-Day ATR ($) 0.069529
20-Day SMA ($) 1.35
12-1 Month Momentum % -5.63
52-Week Range ($) 1.22 - 1.94
Shares Outstanding (Mil) 48.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ikena Oncology Inc Filings

Filing Date Document Date Form
No Filing Data

Ikena Oncology Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Ikena Oncology Inc Frequently Asked Questions

What is Ikena Oncology Inc(IKNA)'s stock price today?
The current price of IKNA is $1.32. The 52 week high of IKNA is $1.94 and 52 week low is $1.22.
When is next earnings date of Ikena Oncology Inc(IKNA)?
The next earnings date of Ikena Oncology Inc(IKNA) is 2025-05-13 Est..
Does Ikena Oncology Inc(IKNA) pay dividends? If so, how much?
Ikena Oncology Inc(IKNA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1